Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting.
Journal Information
Full Title: Mol Immunol
Abbreviation: Mol Immunol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Allergy and Immunology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest The authors declare that they have no conflict of interest."
"This work was supported by the CCHD PhD program of the Austrian Science Fund FWF, project # APW01205FW (JS, EJJ), APP23398FW (MW, EJJ), APP22441FW (DM), by RotePfote – Cancer research for companion animals – grants, project # FA644A0106, FA648A1301 and a von Fircks Fund scholarship for doctoral students (MW)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025